BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 15822128)

  • 1. Cytologic findings and protein expression profiles associated with ductal carcinoma of the breast in ductal lavage specimens using surface-enhanced laser desorption and ionization-time of flight mass spectrometry.
    Mendrinos S; Nolen JD; Styblo T; Carlson G; Pohl J; Lewis M; Ritchie J
    Cancer; 2005 Jun; 105(3):178-83. PubMed ID: 15822128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid.
    Li J; Zhao J; Yu X; Lange J; Kuerer H; Krishnamurthy S; Schilling E; Khan SA; Sukumar S; Chan DW
    Clin Cancer Res; 2005 Dec; 11(23):8312-20. PubMed ID: 16322290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ; Du J; Pang D
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method optimisation for peptide profiling of microdissected breast carcinoma tissue by matrix-assisted laser desorption/ionisation-time of flight and matrix-assisted laser desorption/ionisation-time of flight/time of flight-mass spectrometry.
    Umar A; Dalebout JC; Timmermans AM; Foekens JA; Luider TM
    Proteomics; 2005 Jul; 5(10):2680-8. PubMed ID: 15892168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma. High-throughput biomarker discovery.
    Kuerer HM; Goldknopf IL; Fritsche H; Krishnamurthy S; Sheta EA; Hunt KK
    Cancer; 2002 Dec; 95(11):2276-82. PubMed ID: 12436432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen biomarkers for early diagnosis of lung adenocarcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Yu JK; Zheng S
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):157-61. PubMed ID: 19292069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
    Ricolleau G; Charbonnel C; Lodé L; Loussouarn D; Joalland MP; Bogumil R; Jourdain S; Minvielle S; Campone M; Déporte-Fety R; Campion L; Jézéquel P
    Proteomics; 2006 Mar; 6(6):1963-75. PubMed ID: 16470659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study.
    Streckfus CF; Bigler LR; Zwick M
    J Oral Pathol Med; 2006 May; 35(5):292-300. PubMed ID: 16630293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma.
    Ho DW; Yang ZF; Wong BY; Kwong DL; Sham JS; Wei WI; Yuen AP
    Cancer; 2006 Jul; 107(1):99-107. PubMed ID: 16708360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
    Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
    Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of serum proteomic mass spectrum analysis in breast cancer].
    Ying MG; Chen Q; Ye YB; Chen HJ; Chen X; Zheng HY; Wu F
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):698-702. PubMed ID: 21122387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in situ hybridization of ductal lavage samples identifies malignant phenotypes from cytologically normal cells in women with breast cancer.
    Adduci KM; Annis CE; DeVries S; Chew KL; Boutin J; Magrane G; Ljung BM; Waldman FM; Esserman LJ
    Cancer; 2007 Jun; 111(3):185-91. PubMed ID: 17474121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
    Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
    Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
    de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
    Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.